Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade
A. Mehta, M. Rucevic, E. Sprecher, M. Parikh, J. Chem, D. T. Frederick, E. Woods, L. Bi, D. Lieb, L. Hultin-Rosenberg, J. Guess, R. J. Park, A. Schneider, W. Michaud, B. Miao, , G. M. Boland
The paper identifies plasma proteomic biomarkers that predict non-response to PD1 blockade in melanoma patients and links them to tumor microenvironment biology.
bioRxiv · Feb 2, 2022 · PreprintCancer Biology